• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

Riata Capital Portfolio Company Acuity Eyecare Group Completes Significant Acquisitions in Colorado and Nebraska

Share:

January 14, 2019

Receives Investment from J.P. Morgan Asset Management

Riata Capital Group today announced that its portfolio company Acuity Eyecare Group, an owner and operator of leading North American eyecare groups and optometry practices, has acquired two new regional eyecare groups, totaling 18 locations:

  • ABBA Eye Care, based in Colorado Springs, Colorado, which operates 13 full-service optometry locations in Colorado Springs, Pueblo, Alamosa, Aurora, Fountain, Gunnison, La Junta, Lamar, and Pagosa Springs.
  • EyeCare Specialties, based in Lincoln, Nebraska, which operates 5 full-service optometry locations in Lincoln, Beatrice, and Fremont.

Riata also announced that funds and accounts advised by J.P. Morgan Asset Management have made a substantial equity investment in Acuity to support the company’s continued growth and expansion. The investment from J.P. Morgan positions Riata to achieve its stated plan of building Acuity to 200-300 locations over a three-to-five-year period through the acquisition of additional regional eyecare groups and independent optometry practices.

Acuity now owns nearly 90 locations across 8 states under 10 different local brands, as well as a large, full-service digital lab operation, The First Look Lab, located outside of St. Louis, Missouri. The Company expects to exceed 100 locations by early 2019 based on other eyecare groups under letter of intent and its pipeline of prospects.

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

Eric Anderson, CEO of Acuity Eyecare Group, said: “We are very excited and privileged to add ABBA Eye Care and EyeCare Specialties to our growing Acuity family. Both brands share our values and core purpose as a caring community of local eye care providers. These practices are a great fit for Acuity given their focus on patient care and full-scope optometry. We are very pleased to have received such positive response in the marketplace, as eyecare groups and their providers are enthusiastic about partnering with Acuity.”

Jeff Fronterhouse, Managing Partner of Riata Capital Group, said: “We are excited to have J.P. Morgan Asset Management join us as an equity partner as we continue to build Acuity Eyecare Group into a market-leading eyecare platform. And the addition of ABBA Eye Care and EyeCare Specialties, two medically-oriented optometry groups, is a terrific way to finish out a strong 2018 for Acuity Eyecare Group. We look forward to continued growth and expansion in 2019.”

Riata has been very active since late 2016, having closed 11 acquisitions in the business services, consumer, and healthcare services sectors, with several additional transactions in its pipeline.

Date: January 14, 2019

Source: Cision

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • Garmin to work with University of Kansas Medical Center and more digital health dealsGarmin to work with University of Kansas Medical Center and more digital health deals
  • Buoy Health Adds New Employer-Facing Vaccination ToolBuoy Health Adds New Employer-Facing Vaccination Tool
  • UCB Taps Medisafe to Develop Branded Digital Drug Companions for Antiepileptic MedicationsUCB Taps Medisafe to Develop Branded Digital Drug Companions for Antiepileptic Medications
  • BeiGene and Ensem Therapeutics Announce Partnership to Advance Differentiated CDK2 InhibitorBeiGene and Ensem Therapeutics Announce Partnership to Advance Differentiated CDK2 Inhibitor
  • Particle Dynamics Announces Sale to New Ownership Group Led By BroadOak Capital PartnersParticle Dynamics Announces Sale to New Ownership Group Led By BroadOak Capital Partners
  • Sobi Expands Hematology Portfolio with $1.7B Buy of CTISobi Expands Hematology Portfolio with $1.7B Buy of CTI
  • Outcome Health Agrees to $70M Settlement in Federal Ad Fraud InvestigationOutcome Health Agrees to $70M Settlement in Federal Ad Fraud Investigation
  • Foundation Health | Revolutionizing Healthcare Experiences with InnovationFoundation Health | Revolutionizing Healthcare Experiences with Innovation

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications